KVUE - Kenvue - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US49177J1025

Health Supplements, Skin Care, Personal Care, Baby Care, Oral Care

Kenvue Inc. is a global consumer health company that operates through three distinct business segments: Self Care, Skin Health and Beauty, and Essential Health.

The Self Care segment is dedicated to providing a range of over-the-counter (OTC) products that cater to various health needs. This includes cough, cold, and allergy remedies, pain relief medications, digestive health products, smoking cessation aids, eye care solutions, and other essential health products. Some of the well-known brands under this segment include Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec.

The Skin Health and Beauty segment focuses on providing a diverse range of personal care products that promote healthy skin and beauty. This includes face and body care products, hair care solutions, sun care products, and other personal care items. The segment boasts a portfolio of popular brands such as Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX.

The Essential Health segment is responsible for offering a variety of health and hygiene products that cater to different consumer needs. This includes oral care products, baby care items, women's health products, wound care solutions, and other essential health products. Some of the notable brands under this segment include Listerine, Johnson's, Band-Aid, Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash.

Kenvue Inc. was established in 2022 and is headquartered in Skillman, New Jersey. For more information about the company and its products, visit their official website at https://www.kenvue.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for KVUE - Kenvue  - Stock Price & Dividends

KVUE Stock Overview

Market Cap in USD 35,596m
Sector Consumer Defensive
Industry Household & Personal Products
GiC SubIndustry Personal Care Products
TER 0.00%
IPO / Inception 2023-05-04

KVUE Stock Ratings

Growth 5y -66.2
Fundamental 27.1
Dividend 34.5
Rel. Performance vs Sector -1.95
Analysts 3.63/5
Fair Price Momentum 17.24 USD
Fair Price DCF 28.72 USD

KVUE Dividends

Dividend Yield 12m 4.28%
Yield on Cost 5y 3.09%
Dividends CAGR 5y 0.00%
Payout Consistency 100.0%

KVUE Growth Ratios

Growth 12m -20.30%
Growth Correlation 12m -42%
Growth Correlation 3m -54%
CAGR 5y -23.17%
CAGR/Mean DD 5y -1.08
Sharpe Ratio 12m -1.01
Alpha vs SP500 12m -27.80
Beta vs SP500 5y weekly 0.14
ValueRay RSI 76.73
Volatility GJR Garch 1y 25.13%
Price / SMA 50 -0.05%
Price / SMA 200 -4.01%
Current Volume 11484.7k
Average Volume 20d 17476.3k

External Links for KVUE Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of KVUE stocks?
As of July 27, 2024, the stock is trading at USD 18.69 with a total of 11,484,659 shares traded.
Over the past week, the price has changed by -0.38%, over one month by -2.14%, over three months by -3.03% and over the past year by -22.18%.
What are the forecast for KVUE stock price target?
According to ValueRays Forecast Model, KVUE Kenvue will be worth about 18.6 in July 2025. The stock is currently trading at 18.69. This means that the stock has a potential downside of -0.32%.
Issuer Forecast Upside
Wallstreet Target Price 22.3 19.0
Analysts Target Price 26.7 42.9
ValueRay Target Price 18.6 -0.32